KD [3H]CGP 12177 | n | Protein | Log KD Salmeterol | n | Log KD Salbutamol | n | Log KD Formoterol | n | Log KD Fenoterol | n | |
---|---|---|---|---|---|---|---|---|---|---|---|
fmol/mg | |||||||||||
β2-WT | 0.21 ± 0.02 | 29 | 279 ± 20 | −8.95 ± 0.05 | 30 | −5.94 ± 0.03 | 33 | −8.29 ± 0.03 | 32 | −6.80 ± 0.02 | 30 |
β2-N | 0.29 ± 0.04 | 9 | 389 ± 42 | −9.14 ± 0.05 | 10 | −5.90 ± 0.03 | 11 | −8.25 ± 0.05 | 10 | −6.86 ± 0.03 | 10 |
β2-EL1 | 0.36 ± 0.02 | 9 | 946 ± 97 | −8.99 ± 0.04 | 10 | −5.84 ± 0.03 | 11 | −8.12 ± 0.06 | 10 | −6.61 ± 0.02* | 10 |
β2-EL2 | 0.30 ± 0.01 | 9 | 516 ± 35 | −8.28 ± 0.06 * | 10 | −5.60 ± 0.04* | 11 | −7.74 ± 0.06* | 10 | −6.37 ± 0.03* | 9 |
β2-EL3 | 0.28 ± 0.02 | 9 | 778 ± 63 | −6.74 ± 0.03*,# | 10 | −5.68 ± 0.03* | 11 | −7.89 ± 0.05* | 10 | −6.51 ± 0.03* | 10 |
β2-TM1 | 0.17 ± 0.06 | 15 | 138 ± 8 | −9.11 ± 0.10 | 8 | −5.83 ± 0.04 | 9 | −8.18 ± 0.04 | 8 | −6.82 ± 0.03 | 9 |
β2-TM2 | 0.22 ± 0.02 | 11 | 405 ± 41 | −8.57 ± 0.08* | 7 | −5.76 ± 0.03 | 7 | −8.27 ± 0.09 | 7 | −7.16 ± 0.10* | 7 |
β2-TM3 | 0.34 ± 0.03 | 10 | 1037 ± 113 | −8.84 ± 0.05 | 8 | −5.77 ± 0.07 | 8 | −7.66 ± 0.05* | 8 | −6.15 ± 0.04* | 7 |
β2-TM4 | 0.25 ± 0.03 | 11 | 458 ± 64 | −8.96 ± 0.03 | 7 | −5.97 ± 0.07 | 7 | −8.30 ± 0.03 | 7 | −6.87 ± 0.02 | 8 |
β2-TM5 | 0.32 ± 0.03 | 10 | 849 ± 83 | −9.00 ± 0.05 | 7 | −5.84 ± 0.03 | 8 | −8.05 ± 0.07 | 8 | −6.48 ± 0.03* | 6 |
β2-TM6 | 0.75 ± 0.06 | 9 | 728 ± 58 | −7.37 ± 0.03* | 7 | −5.89 ± 0.08 | 7 | −8.06 ± 0.07 | 8 | −6.65 ± 0.04 | 7 |
β2-TM7 | 0.14 ± 0.02 | 14 | 67 ± 5 | −7.57 ± 0.06* | 8 | −5.83 ± 0.06 | 10 | −7.57 ± 0.04* | 9 | −6.16 ± 0.03* | 10 |
β1-WT | 0.32 ± 0.02 | 28 | 534 ± 33 | −5.80 ± 0.02 | 27 | −4.80 ± 0.02 | 27 | −6.02 ± 0.02 | 25 | −5.09 ± 0.03 | 27 |
β1-N | 0.50 ± 0.02 | 6 | 1309 ± 126 | −5.60 ± 0.01* | 7 | −4.71 ± 0.02 | 7 | −5.90 ± 0.02 | 6 | −4.95 ± 0.05 | 7 |
β1-EL1 | 0.31 ± 0.01 | 9 | 497 ± 39 | −5.69 ± 0.05 | 7 | −4.74 ± 0.03 | 7 | −6.10 ± 0.04 | 6 | −5.14 ± 0.02 | 7 |
β1-EL2 | 0.58 ± 0.03 | 9 | 1100 ± 111 | −5.72 ± 0.03 | 7 | −4.74 ± 0.04 | 7 | −6.08 ± 0.04 | 6 | −5.13 ± 0.04 | 7 |
β1-EL3 | 0.54 ± 0.04 | 9 | 384 ± 30 | −6.25 ± 0.06* | 7 | −5.01 ± 0.03* | 7 | −6.35 ± 0.06* | 6 | −5.43 ± 0.06* | 7 |
β1-TM1 | 0.30 ± 0.02 | 11 | 372 ± 47 | −5.75 ± 0.05 | 12 | −4.74 ± 0.03 | 12 | −6.03 ± 0.03 | 8 | −5.05 ± 0.07 | 8 |
β1-TM2 | 0.26 ± 0.03 | 10 | 567 ± 58 | −5.50 ± 0.03* | 12 | −5.09 ± 0.02* | 12 | −6.56 ± 0.05* | 8 | −5.54 ± 0.06* | 8 |
β1-TM3 | 0.48 ± 0.03 | 10 | 1994 ± 214 | −5.73 ± 0.02 | 12 | −4.67 ± 0.03 | 12 | −5.95 ± 0.03 | 8 | −5.06 ± 0.07 | 8 |
β1-TM4 | 0.26 ± 0.02 | 12 | 233 ± 18 | −5.91 ± 0.04 | 12 | −4.84 ± 0.03 | 12 | −6.31 ± 0.05* | 8 | −5.06 ± 0.08 | 8 |
β1-TM5 | 0.25 ± 0.02 | 12 | 359 ± 30 | −5.82 ± 0.04 | 11 | −4.86 ± 0.04 | 12 | −6.17 ± 0.03 | 8 | −5.20 ± 0.05 | 8 |
β1-TM6 | 0.29 ± 0.01 | 19 | 1207 ± 100 | −5.89 ± 0.02 | 18 | −5.01 ± 0.03* | 18 | −6.37 ± 0.03* | 7 | −5.45 ± 0.08* | 7 |
β1-TM7 | 0.57 ± 0.04 | 9 | 2078 ± 133 | −6.44 ± 0.02* | 17 | −5.42 ± 0.02* | 18 | −6.93 ± 0.05* | 7 | −5.86 ± 0.09* | 7 |
↵* P < 0.001. One-way analysis of variance with post hoc Newman-Keuls comparing values from the mutant receptors with those obtained from the β2-WT or the β1-WT. Thus, the log KD for salmeterol at the β2-EL2 is different from that obtained from the β2-WT with P < 0.001. Likewise, the log KD for salmeterol at the β1-EL3 is different from that obtained from the β1-WT with P < 0.001; #P < 0.001. One-way analysis of variance with post hoc Newman-Keuls comparing each value with all other values in this set. Thus, the log KD for salmeterol at β2-EL3 is different from that obtained for β2-WT, β2-N, β2-EL1, β2-EL2, β2-TM1, β2-TM2, β2-TM3, β2-TM4, β2-TM5, β2-TM6, and β2-TM7 with P < 0.001 in all cases.